ArticleInvestigational new drugs2022

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.

Patricia LoRusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.